| Literature DB >> 30293575 |
Adrian Thorogood1, Anna Mäki-Petäjä-Leinonen2, Henry Brodaty3, Gratien Dalpé4, Chris Gastmans5, Serge Gauthier6, Dianne Gove7, Rosie Harding8, Bartha Maria Knoppers4, Martin Rossor9, Martin Bobrow10.
Abstract
Consent is generally required for research and sharing rich individual-level data but presents additional ethical and legal challenges where participants have diminished decision-making capacity. We formed a multi-disciplinary team to develop best practices for consent in data-intensive dementia research. We recommend that consent processes for research and data sharing support decision-making by persons with dementia, protect them from exploitation, and promote the common good. Broad consent designed to endure beyond a loss of capacity and combined with ongoing oversight can best achieve these goals. Persons with dementia should be supported to make decisions and enabled to express their will and preferences about participation in advance of a loss of capacity. Regulatory frameworks should clarify who can act as a representative for research decisions. By promoting harmonization of consent practices across institutions, sectors, and countries, we hope to facilitate data sharing to accelerate progress in dementia research, care, and prevention.Entities:
Keywords: Advance directive; Alzheimer's disease; Broad consent; Consent process; Dementia; International data sharing; Representative; Research participation; Supported decision-making; Will and preferences
Mesh:
Year: 2018 PMID: 30293575 DOI: 10.1016/j.jalz.2018.05.011
Source DB: PubMed Journal: Alzheimers Dement ISSN: 1552-5260 Impact factor: 21.566